Skip to search formSkip to main contentSkip to account menu

Bufexamac

Known as: p-Butoxyphenylacethydroxamic Acid, p Butoxyphenylacethydroxamic Acid, Benzeneacetamide, 4-butoxy-N-hydroxy- 
A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
National Institutes of Health

Related topics

Related topics

11 relations

Broader (1)

Anti-Inflammatory Agents, Non-Steroidal

Narrower (3)

Bufexamac-ratiopharmDroxarylJomax
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Kontaktallergie durch Bufexamac unter dem Bild einer chronischen Pigmentpurpura
ZusammenfassungWir berichten über den Fall einer durch topisches Bufexamac bedingten hämatogen gestreuten allergischen… 
1982
1982
Contact Dermatitis to Bufexamac
Description of 3 cases of contact dermatitis to bufexamac cream, which is largely used in dermatology as a nonsteroid anti… 
1979
1979
Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial.
A double-blind controlled study was carried out in 72 patients with atopic or contact dermatitis, who were randomly allocated to… 
1977
1977
Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
The effect of a new non-steroid anti-inflammatory substance (bufexamac) in a special constituent was compared with that of 0.1… 
1973
1973
Contact allergy to bufexamac.
A 44-year-old woman developed an allergic contact eczema due to bufexamac (Droxaryl cream) after the use of this cream for a… 
1973
1973
Étude du bufexamac crème et du bufexamac onguent dans le traitement de diverses dermatoses
The authors conducted three studies on the activity of bufexamac 5% cream or ointment in dermatoses. – A double-blind trial where… 
1973
1973
Allergy to bufexamac.
1972
1972
Elimination of 4-n-butoxyphenylacethydroxamic acid (bufexamac) in man.
Abstract A GLC determination showed that about 80% of a dose of bufexamac (125–500 mg.) can be recovered from urine after acid… 
1971
1971
Estimation of 4-butoyphenylacetohydroxamic acid utilizing the Lossen rearrangement.
A sensitive and specific GLC method for the determination of 4-butoxyphenylacetohydroxamic acid (bufexamac) is described. The… 
1970
1970
Teratological studies of p-butoxyphenylacethydroxamic acid (CP 1044 J3) in rats and rabbits.